Top Abstract Purchase Related
Home
>
Node
>
Subnode

The use of metabolic therapy in the treatment of ischemic heart disease in hemodynamically formed insignificant aortic stenosis with chronic heart failure

Kuriata, A.V.; Karavanskaia, I.L.; Kushnir, I.S.

Likars'ka Sprava 2011(7-8): 51-58

2011

ISSN/ISBN: 1019-5297
PMID: 22768738
Document Number: 655457
Analysis of medical treatment was conducted with justified using of the metabolic component in a complex therapy of ischemic heart disease with chronic heart failure in hemodynamically formed insignificant aortic stenoses. The effect of metabolic correction is shown for pharmaceutical compounds Meldoniya in the form of Vasonat manufactured by "OlainFarm" (Latvia). Positive results of maintenance of systolic activity and prevention of diastolic dysfunction of myocardium were presented. The application of Vasonat in appropriate for the stabilization of adaptive properties of the myocardium and prophylaxis of the development of critical indicators of heart failure in this combined.

Document emailed within 1 workday
Secure & encrypted payments

Safarova, M.S.; Imaev, T.Ē; Lorie, I.I.; Saidova, M.A.; Ezhov, M.V. 2015: Transcatheter treatment of degenerative critical aortic valve stenosis in a patient with severe heart failure and chronic lymphocytic leukemia Kardiologiia 55(1): 82-87
Shugushev, K.K.; Eneeva, L.S.; Khadzugov, A.B. 2003: Parameters of spectral-temporal maps of signal averaged ECG in patients with ischemic heart disease and chronic heart failure Kardiologiia 43(9): 8-10
Sukhorukova, E.S.; Solov'ev, V.V.; Salishcheva, L.E.; Ovcharenko, K.I.; Chernikov, V.A. 1988: Relation between hemodynamic reactions to corinfar and the status of peripheral circulation in middle-aged and elderly patients with ischemic heart disease and chronic heart failure Kardiologiia 28(7): 81-83
Pribylov, S.A. 2006: Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease Kardiologiia 46(9): 36-40
Amosov, N.M.; Knyshov, G.V.; Mintser, O.P.; Ugarov, B.N.; Kononenko, I.N. 1982: Dynamics of cardiac minute volume in the diagnosis of heart failure in acquired heart defects and ischemic heart disease in the postoperative period Kardiologiia 22(10): 21-23
Fedorova, T.A.; Il'ina, I.V.; Sotnikova, T.I.; Rybakova, M.K. 2004: Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease Klinicheskaia Meditsina 82(11): 15-20
Rozdil'skaia, O.N.; Kaduk, I.G.; Biazrova, V.V. 1993: The use of sodium nitroprusside aerosols combined with ultrasound in the combined treatment of patients with ischemic heart disease and heart failure Likars'ka Sprava 4: 97-100
Aleksandrova, E.B. 2013: Chronic heart failure in patients with arterial hypertension and ischemic heart desease: age and gender characteristics Kardiologiia 53(7): 40-44
Goncharova, L.N.; Danilova, I.V. 1987: Use of korinfar in the early stages of heart failure in ischemic heart disease Sovetskaia Meditsina 12: 85-88
Nagai, M.; Kario, K. 2014: Ischemic heart disease, heart failure, and their effects on cognitive function Nihon Rinsho. Japanese Journal of Clinical Medicine 72(4): 715-720
Dunaev, V.V.; Berezin, A.E. 1998: A comparison of the clinical efficacy of enalapril maleate analogs in patients with heart failure and ischemic heart disease Eksperimental'naia i Klinicheskaia Farmakologiia 61(4): 20-22
Buslenko, N.S.; Buziashvili, I.I.; Koksheneva, I.V.; Asymbekova, E.U.; Sherstiannikova, O.M. 2005: Interrelationship between functional state of the right ventricle and severity of heart failure in patients with ischemic heart disease and depressed left ventricular function Kardiologiia 45(12): 25-30
Bardov, V.G.; Shmuter, G.M.; Cherniavskaia, E.N.; Suchkov, B.P.; Maslenko, A.A.; Omel'chuk, S.T.; Ivanov, E.V.; Lebedeva, O.V. 1992: The relation between oxidative processes and the glycogen content in the heart and liver of rabbits with chronic ischemic heart disease Ukrainskii Biokhimicheskii Zhurnal 64(6): 101-104
Maeda, S.; Miyamoto, T.; Murata, H.; Kaku, K.; Yamashita, K.; Iwaoka, S.; Yasuoka, T. 1989: Influence of ischemic heart disease on early and late mortality after aortic reconstruction for abdominal aortic aneurysm and aortoiliac occlusive disease Nihon Geka Gakkai Zasshi 90(9): 1471-1474
Li, L.; Yi, S. 2015: Heart rate reduction is not the therapeutic target in the chronic heart failure therapy Zhonghua Xin Xue Guan Bing Za Zhi 43(3): 197-199
Mikhin, V.P.; Kharchenko, A.V.; Sharova, V.G.; Cherniatina, M.A.; Mal'tseva, E.V. 2012: Efficacy of the use of coenzyme q10 at the background of traditional therapy of chronic ischemic heart disease Kardiologiia 52(10): 4-8
Wu, C.; Yang, Y.-j.; Zhao, X.-y.; Zhang, J.; Huang, J.; Wei, B.-q.; Sun, H.-s.; Wang, W.; Yan, P. 2010: Diagnostic value of NT-proBNP in identifying aortic stenosis patients with heart failure Zhonghua Xin Xue Guan Bing Za Zhi 38(7): 579-583
Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Möckel, S. 1977: Current treatment of chronic ischemic heart disease Zeitschrift für Arztliche Fortbildung 71(8): 386-388
Lebedev, L.V.; Vinogradov, A.G.; Sedletskiĭ, I.I.; Shneĭder, I.A.; Pizin, V.M.; Azovtsev, R.A.; Alekseeva, N.S.; Gordeev, M.L.; Polikarpov, I.S.; Kovalev, V.A. 1990: Surgical treatment of chronic ischemic heart disease Khirurgiia 5: 11-16